文献速递重症综合管理与镇静镇痛心脑血管急症

接受与未接受神经重症培训的提供者对ICU患者的预后预测

Prognostication of ICU Patients by Providers with and without Neurocritical Care Training.
PubMed 文献 · Neurocrit Care · 2022-03-22
一句话结论神经重症主治医师比其他提供者更常预期良好结局,且对不良功能结局的预测阳性预测值更高(96% vs 88%/82%/85%),但各组对良好结局的预测阳性预测值均一般(63%-71%)。

该前瞻性队列连续纳入因原发神经系统疾病或神经系统并发症插管≥72小时的患者,随访6个月功能结局(mRS)。医疗ICU主治、神经重症主治、住院医师和护士在6个月时预测mRS结局。在176例被四组均预测的患者中,6个月时54例(31%)结局良好、122例(69%)结局不良。神经重症主治预期结局更好(p<0.001),其不良结局预测阳性预测值96%(95%CI 89-99%)高于医疗ICU主治88%(95%CI 80-93%)、住院医师82%(95%CI 74-88%)、护士85%(95%CI 77-91%),对应p值分别为0.047、0.002、0.012;良好结局预测阳性预测值组间相似。

要点

  • 神经重症主治对不良结局的预测阳性预测值为96%(95%CI 89-99%),高于医疗ICU主治88%(95%CI 80-93%,p=0.047)、住院医师82%(95%CI 74-88%,p=0.002)和护士85%(95%CI 77-91%,p=0.012)。
  • 神经重症主治比其他提供者更常预期良好结局(p<0.001)。
  • 良好结局预测阳性预测值组间相似:医疗ICU主治65%(95%CI 52-76%)、神经重症主治63%(95%CI 51-73%)、住院医师71%(95%CI 55-84%)、护士64%(95%CI 50-76%)。
  • 排除67例撤除生命支持治疗的患者后,神经重症主治对不良结局的预测仍较好(90% [95%CI 75-97%] vs 医疗ICU主治73% [95%CI 59-84%],p=0.064)。
  • 6个月时176例被四组均预测的患者中,54例(31%)结局良好、122例(69%)结局不良。

适用人群与场景

  • 连续纳入因原发神经系统疾病或神经系统并发症插管≥72小时的患者,前瞻性随访6个月功能结局。
  • 纳入分析人群为176例由四组提供者(医疗ICU主治、神经重症主治、住院医师、护士)均预测mRS评分的患者。

诊断标准与关键阈值

  • 良好功能结局定义为6个月mRS评分0-3分;不良功能结局定义为6个月mRS评分4-6分。

研究设计与关键结果

  • 前瞻性队列研究,共纳入289例患者,其中176例由四组提供者均预测mRS评分并纳入主要结局分析。
  • 6个月时54例(31%)患者结局良好,122例(69%)结局不良。
  • 神经重症主治比其他提供者更常预期良好结局(p<0.001)。
  • 不良结局预测阳性预测值:神经重症主治96%(95%CI 89-99%)vs 医疗ICU主治88%(95%CI 80-93%,p=0.047),vs 住院医师82%(95%CI 74-88%,p=0.002),vs 护士85%(95%CI 77-91%,p=0.012)。
  • 排除67例撤除生命支持治疗的患者后,神经重症主治对不良结局的预测仍较好(90% [95%CI 75-97%] vs 医疗ICU主治73% [95%CI 59-84%],p=0.064)。
  • 良好结局预测阳性预测值组间相似:医疗ICU主治65%(95%CI 52-76%)、神经重症主治63%(95%CI 51-73%)、住院医师71%(95%CI 55-84%)、护士64%(95%CI 50-76%)。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,神经重症医师比其他提供者更常预期良好结局,且更擅长预测不良功能结局;所有提供者对良好结局的预测阳性预测值均一般。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Predictions of functional outcome in neurocritical care (NCC) patients impact care decisions. This study compared the predictive values (PVs) of good and poor functional outcome among health care providers with and without NCC training.

METHODS: Consecutive patients who were intubated for ≥ 72 h with primary neurological illness or neurological complications were prospectively enrolled and followed for 6-month functional outcome. Medical intensive care unit (MICU) attendings, NCC attendings, residents (RES), and nurses (RN) predicted 6-month functional outcome on the modified Rankin scale (mRS). The primary objective was to compare these four groups' PVs of a good (mRS score 0-3) and a poor (mRS score 4-6) outcome prediction.

RESULTS: Two hundred eighty-nine patients were enrolled. One hundred seventy-six had mRS scores predicted by a provider from each group and were included in the primary outcome analysis. At 6 months, 54 (31%) patients had good outcome and 122 (69%) had poor outcome. Compared with other providers, NCC attendings expected better outcomes (p < 0.001). Consequently, the PV of a poor outcome prediction by NCC attendings was higher (96% [95% confidence interval [CI] 89-99%]) than that by MICU attendings (88% [95% CI 80-93%]), RES (82% [95% CI 74-88%]), and RN (85% [95% CI 77-91%]) (p = 0.047, 0.002, and 0.012, respectively). When patients who had withdrawal of life-sustaining therapy (n = 67) were excluded, NCC attendings remained better at predicting poor outcome (NCC 90% [95% CI 75-97%] vs. MICU 73% [95% CI 59-84%], p = 0.064). The PV of a good outcome prediction was similar among groups (MICU 65% [95% CI 52-76%], NCC 63% [95% CI 51-73%], RES 71% [95% CI 55-84%], and RN 64% [95% CI 50-76%]).

CONCLUSIONS: Neurointensivists expected better outcomes than other providers and were better at predicting poor functional outcomes. The PV of a good outcome prediction was modest among all providers.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Finley Caulfield A, Mlynash M, Eyngorn I, et al. Prognostication of ICU Patients by Providers with and without Neurocritical Care Training. Neurocrit Care. 2022. PMID: 35314970. doi:10.1007/s12028-022-01467-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。